Tirzepatide
Activates both GLP-1 and GIP pathways simultaneously — the dual hormone mechanism produces the highest average weight loss of any GLP-1 medication currently available. Up to 22.5% body weight lost at 72 weeks in the SURMOUNT-1 trial.
Mounjaro and Wegovy — prescribed by our doctors, monitored monthly, supported by a multidisciplinary team. Not a pharmacy. A programme built for results that are safe, superior, and sustainable.
GLP-1 medication mimics a hormone your gut naturally produces after eating — one that signals fullness, slows digestion, and stabilises blood sugar. In most people with obesity, this signal is weaker than it should be. The medication corrects that at the source.
Your brain receives the "full" signal faster and with smaller meals — you eat less without feeling deprived or restricted.
Food stays in the stomach longer, reducing the rate at which glucose enters the bloodstream and extending the feeling of satiety.
Insulin response is improved significantly — which is why GLP-1 medication is especially powerful in patients with Type 2 diabetes or insulin resistance alongside obesity.
All three are available through the GLP-1 Success Programme. Your eligibility assessment and metabolic panel determine which molecule and dose is appropriate for your profile.
Activates both GLP-1 and GIP pathways simultaneously — the dual hormone mechanism produces the highest average weight loss of any GLP-1 medication currently available. Up to 22.5% body weight lost at 72 weeks in the SURMOUNT-1 trial.
The most studied GLP-1 medication, with over five years of safety data and the only weight loss injection with a proven cardiovascular benefit (SELECT trial). Up to 21% body weight loss. Preferred where diabetes management alongside weight loss is the goal.
The same active molecule as Wegovy, available at a lower cost for eligible members. Doctor-assessed eligibility required — not available without a prescription and metabolic panel review. Our doctors confirm suitability at the eligibility consultation.
GLP-1 medication works best inside a structured clinical programme. Without one, most members lose muscle alongside fat — and regain the weight when medication is tapered. The GLP-1 Success Programme is designed so that doesn't happen.
We track blood markers alongside weight — because returning to health is the goal, and the scale is only part of the picture.
Based on clinical trial averages for each medication. Your doctor will confirm your personalised projection at consultation.
"I'd been on metformin for six years. Four months after starting the programme my doctor said I could stop. The weight was the side effect — the diabetes reversal was the point."
"The nausea in the first two weeks was real. But the team managed it — slower dose increase, diet adjustments. By month two it was gone. By month five my cardiologist was calling it a success."
Dr. Neha Shah trained in bariatric and metabolic surgery at world-leading centres in the United States and Taiwan — a credential held by fewer than 50 surgeons in India. She co-founded The Good Weight to give patients a genuine clinical pathway before surgery becomes the only answer.
Six steps. One team. Everything coordinated.
Clear answers to the questions we hear most often before starting a medically guided weight-loss programme.
Nausea is the most common — typically in weeks 1–4 during dose escalation. We manage this with a slow dose protocol and WhatsApp support from our clinical care team. Most members report significant reduction after month one. Serious side effects are rare and screened for at the metabolic panel stage.
This is a real risk on GLP-1 medication without a programme. Our muscle preservation protocol — protein targets, resistance exercise guidance, and monthly body composition monitoring — is specifically designed to prevent this. It's one of the core reasons the programme exists alongside the prescription.
No. GLP-1 medication is a tool, not a life sentence. Our programme includes nutrition and lifestyle coaching so that results are maintained when medication is tapered. The exit plan is built from day one — you always know what happens when the injection stops.
Your eligibility assessment and metabolic panel screen all contraindications before prescribing. GLP-1 medication is contraindicated in certain conditions — including personal or family history of medullary thyroid cancer and pancreatitis. We check for all of these before anything is prescribed.
The programme fee is ₹5,000/month — this covers your doctor consultations, blood monitoring, coaching, and clinical care team access. Medication cost is additional and depends on which molecule is prescribed. Generic semaglutide is available at a lower cost for eligible members. We'll give you a full cost breakdown before you commit to anything.
In most cases this is a dose or protocol issue, not a medication failure. Many patients we see have been given an initial dose and left without monitoring, dose escalation, or any nutritional support. Our doctors will review your history, understand what happened, and build a programme that addresses it.
Clear answers to the questions we hear most often before starting a medically guided weight-loss programme.
Nausea is the most common — typically in weeks 1–4 during dose escalation. We manage this with a slow dose protocol and WhatsApp support from our clinical care team. Most members report significant reduction after month one. Serious side effects are rare and screened for at the metabolic panel stage.
This is a real risk on GLP-1 medication without a programme. Our muscle preservation protocol — protein targets, resistance exercise guidance, and monthly body composition monitoring — is specifically designed to prevent this. It's one of the core reasons the programme exists alongside the prescription.
No. GLP-1 medication is a tool, not a life sentence. Our programme includes nutrition and lifestyle coaching so that results are maintained when medication is tapered. The exit plan is built from day one — you always know what happens when the injection stops.
Your eligibility assessment and metabolic panel screen all contraindications before prescribing. GLP-1 medication is contraindicated in certain conditions — including personal or family history of medullary thyroid cancer and pancreatitis. We check for all of these before anything is prescribed.
The programme fee is ₹5,000/month — this covers your doctor consultations, blood monitoring, coaching, and clinical care team access. Medication cost is additional and depends on which molecule is prescribed. Generic semaglutide is available at a lower cost for eligible members. We'll give you a full cost breakdown before you commit to anything.
In most cases this is a dose or protocol issue, not a medication failure. Many patients we see have been given an initial dose and left without monitoring, dose escalation, or any nutritional support. Our doctors will review your history, understand what happened, and build a programme that addresses it.